Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This transcript is a sense intronic long non-coding RNA located within the intronic regions of RP11-770J1.8, as classified by Ensembl and Vega transcript biotypes. "Sense intronic" indicates the transcript is found on the same DNA strand inside an intron of a coding gene, but it does not overlap coding exons and does not encode a protein[1]. The locus, and specifically the transcript, do not currently have recognized biological function, disease association, molecular interaction, or therapeutic relevance in primary literature, clinical databases, or drug discovery resources. This entity is not recognized as a receptor, enzyme, transporter, or canonical drug target[1]. While some related lncRNAs (like RP11-770J1.4/770J1.3) are researched for roles in cancer or immune modulation[2][4], the specific ENSG00000295444 transcript has no curated disease or functional evidence. "RP11" refers to a BAC clone used in the human genome project and by convention names lncRNA loci with uncertain function; these names are not gene symbols. "sense intronic" is an Ensembl/Vega biotype indicating intronic lncRNA, not protein-coding and not a validated target[1]. Because "ENSG00000295444" does not correspond to a validated therapeutic target, nor does it have established molecular function, disease role, or drug interaction, this entry is not suitable for downstream target-based drug discovery, annotation, or structured pharmacological data. In summary: ENSG00000295444 is best described as a non-coding RNA transcript of unknown function, located within the intron of RP11-770J1.8, and is not an established or actionable molecular target. There is no evidence from literature or clinical resources demonstrating any role in disease, drug interaction, or as a biomarker[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to RP11-770J1.8 (ENSG00000295444).